Xtrackers MSCI World Health Care

Global companies

(XWHS)
£42.45
Previous business day’s close price
+£3.74 (+9.66%)
max available period
£37.33
£45.20

17 Aug 23
29 Oct 24

Details

ETF description

This ETF aims to invest in companies that operate within the global healthcare sector. It includes a variety of businesses involved in pharmaceuticals, biotechnology, medical devices, and healthcare services. By tracking a specific index that represents this sector, the ETF provides investors with a way to gain exposure to companies that are working to improve health outcomes and innovate in medical treatments.

Investors interested in the healthcare industry may find this ETF appealing, especially those looking for growth opportunities as the sector continues to evolve. The healthcare field often experiences demand regardless of economic conditions, making it a sector that some investors view as resilient

Issuer details

Xtrackers is a large and established provider of high quality ETFs and exchange traded commodities (ETCs). It is the ETF and ETC segment of the German asset manager DWS.

Xtrackers ETFs are listed on eleven stock exchanges globally and have over £169.53bn (as at June 2024) in assets under management, making Xtrackers one of the largest providers of ETFs and ETCs by AUM.

Index details

The MSCI World Health Care TRN Index aims to reflect the performance of large and mid‑cap companies from global developed markets part of the Health care sector as classified by GICS. Weighted by free‑float adjusted market capitalisation and is reviewed on a quarterly basis.

ETF Breakdown

Lilly
9.1%
Unitedhealth Group Inc
6.5%
Johnson & Johnson
4.9%
Novo Nordisk As Class B
4.6%
Abbvie Inc
4.1%
Merck & Co Inc
3.4%
Astrazeneca plc
3.0%
Novartis AG
2.8%
Thermo Fisher
2.8%
Abbott Laboratories
2.5%
Danaher Corp.
2.2%
AMGEN Inc.
2.1%
Intuitive Surgical Inc
2.1%
Pfizer Inc.
2.1%
Boston Scientific Corp.
1.6%
Vertex Pharmaceuticals, Inc.
1.5%
Sanofi
1.5%
Stryker Corp.
1.5%
Elevance Health Inc
1.4%
Medtronic Plc
1.4%
Regeneron Pharmaceuticals, Inc.
1.3%
Bristol‑Myers Squibb Co.
1.3%
Gilead Sciences, Inc.
1.3%
Cigna Group (The)
1.3%
CSL Ltd.
1.2%
Zoetis Inc
1.1%
CVS Health Corp
1.0%
GSK Plc
1.0%
HCA Healthcare Inc
1.0%
EssilorLuxottica
0.9%
Becton, Dickinson And Co.
0.9%
Mckesson Corporation
0.8%
Daiichi Sankyo Co., Ltd.
0.7%
Hoya
0.6%
Alcon
0.6%
Lonza Group AG
0.6%
Takeda Pharmaceutical Co
0.5%
Amerisource Bergen Corp.
0.5%
IQVIA
0.5%
Edwards Lifesciences Corp
0.5%
Agilent Technologies Inc.
0.5%
Ge Healthcare Technologies Inc
0.5%
Idexx Laboratories, Inc.
0.5%
Alnylam Pharmaceuticals Inc
0.5%
Centene Corp.
0.5%
Resmed Inc.
0.4%
Veeva Systems Inc
0.4%
argenx SE
0.4%
Chugai Ro Co Ltd
0.4%
Humana Inc.
0.4%
Mettler‑Toledo International, Inc.
0.4%
Bayer AG
0.3%
Dexcom Inc
0.3%
Biogen Inc
0.3%
Cardinal Health, Inc.
0.3%
Terumo Corporation
0.3%
Koninklijke Philips N.V.
0.3%
Otsuka Holdings Co Ltd
0.3%
UCB SA
0.3%
Illumina Inc
0.3%
Steris Plc
0.3%
Olympus Corp.
0.3%
Merck KGAA
0.3%
Zimmer Biomet Holdings Inc
0.3%
Cooper Inc
0.3%
West Pharmaceutical Services, Inc.
0.3%
Waters Corp.
0.3%
Astellas Pharma Inc.
0.3%
Teva‑ Pharmaceutical Industries Ltd.
0.2%
Molina Healthcare Inc
0.2%
Hologic, Inc.
0.2%
Baxter International Inc.
0.2%
Moderna Inc
0.2%
Sonova Holding AG
0.2%
Labcorp Holdings Inc Usd Npv
0.2%
Sandoz Group Ag Chf 0.05
0.2%
Avantor
0.2%
Straumann Holding AG
0.2%
Quest Diagnostics, Inc.
0.2%
Coloplast AS
0.2%
Insulet Corporation
0.2%
Siemens Healthineers AG
0.2%
United Therapeutics Corp
0.2%
Fresenius SE & Co. KGaA
0.2%
Align Technology, Inc.
0.2%
Perkinelmer, Inc.
0.2%
Genmab
0.2%
Universal Health Services, Inc.
0.2%
Viatris Inc
0.2%
Biomarin Pharmaceutical Inc.
0.2%
Exact Sciences Corp.
0.2%
Fisher & Paykel Healthcare Corporation Limited
0.2%
Smith & Nephew plc
0.2%
Cochlear Ltd.
0.2%
Neurocrine Biosciences, Inc.
0.1%
Bio‑Techne Corp
0.1%
Teleflex Incorporated
0.1%
Roche Holding AG
0.1%
Catalent Inc.
0.1%
Royalty Pharma plc
0.1%
Incyte Corp.
0.1%
Solventum Corp
0.1%
Shionogi & Co. Ltd.
0.1%
Charles River Laboratories International Inc.
0.1%
Qiagen N.V.
0.1%
Sysmex Corporation
0.1%
Henry Schein Inc.
0.1%
Eisai Co Ltd
0.1%
DaVita Inc
0.1%
Sonic Healthcare
0.1%
Fresenius Medical Care AG & Co. KGaA
0.1%
Eurofins Scientific S.E.
< 0.1%
Deutsche Global Liquidity Seri
< 0.1%
Zealand Pharma A/S.
< 0.1%
Pro Medicus
< 0.1%
Bio‑Rad Laboratories Inc.
< 0.1%
Sartorius AG
< 0.1%
Recordati Industria Chimica e Farmaceutica SpA
< 0.1%
Sartorius Stedim Biotech S.A.
< 0.1%
Orion Corp (finland)
< 0.1%
Swedish Orphan Biovitrum AB
< 0.1%
Galderma Group Ag
< 0.1%
Ramsay Health Care
< 0.1%
M3, Inc.
< 0.1%
Ono Pharmaceutical Co. Ltd
< 0.1%
Biomerieux
< 0.1%
Ipsen
< 0.1%
Getinge AB
< 0.1%
Hikma Pharmaceuticals Plc
< 0.1%
Kyowa Kirin Co. Ltd.
< 0.1%
Demant AS
< 0.1%
Amplifon
< 0.1%
Grifols SA
< 0.1%
Carl Zeiss Meditec
< 0.1%
Bachem Holding AG
< 0.1%
Diasorin S.p.A.
< 0.1%
Others
< 0.1%
£42.45
Previous business day’s close price

Capital at risk

Why InvestEngine

Unbeatable value

From commission‑free investing, to zero‑ISA fees, we’re proud of our low fees.
Here's how we're able to do it

Choice of 700+ ETFs

Low cost, diversified, index‑tracking of stock markets, bonds and commodities.
View our ETF range

Actionable insights

Know exactly which companies, sectors and regions are in your portfolio.

Powerful automation

Grow your wealth the easy way with automated investing features

Easy diversification

Fractional investing lets you put as little as £1 in any ETF.

DIY or Managed

Build and manage your own portfolio or leave it to us.
ETFs have spreads and annual charges and come with risks like market volatility, liquidity, and concentration, and may not always accurately track their index. Past performance and forecasts are not reliable indicators of future results. The value of your investments, including any income, can rise or fall. You may get back less than you originally invested.
Whenever you invest, your capital is at risk
This could mean the value of your investments goes down as well as up.
Understand more about investment risk.
© InvestEngine Limited 2024. All rights reserved.